Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Corcept Therapeutics
ClinicalTrials.gov Identifier:
NCT00146523
First received: September 2, 2005
Last updated: February 14, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2006
  Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)